Sturgeon SR - Search Results

1

Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.

Schairer C, Hill D, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Sherman ME. Schairer C, et al. Among authors: sturgeon sr. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1660-5. doi: 10.1158/1055-9965.EPI-05-0017. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16030098

2

Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women.

Schairer C, Hill D, Sturgeon SR, Fears T, Pollak M, Mies C, Ziegler RG, Hoover RN, Sherman ME. Schairer C, et al. Among authors: sturgeon sr. Int J Cancer. 2004 Feb 20;108(5):773-9. doi: 10.1002/ijc.11624. Int J Cancer. 2004. PMID: 14696106 Free article.

3

Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.

Adly L, Hill D, Sherman ME, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Schairer C. Adly L, et al. Among authors: sturgeon sr. Int J Cancer. 2006 Nov 15;119(10):2402-7. doi: 10.1002/ijc.22203. Int J Cancer. 2006. PMID: 16894564 Free article.

4

Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls.

Sturgeon SR, Balasubramanian R, Schairer C, Muss HB, Ziegler RG, Arcaro KF. Sturgeon SR, et al. Epigenetics. 2012 Nov;7(11):1258-67. doi: 10.4161/epi.22220. Epub 2012 Sep 17. Epigenetics. 2012. PMID: 22986510 Free PMC article.

5

Prediagnostic White Blood Cell DNA Methylation and Risk of Breast Cancer in the Prostate Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort.

Sturgeon SR, Sela DA, Browne EP, Einson J, Rani A, Halabi M, Kania T, Keezer A, Balasubramanian R, Ziegler RG, Schairer C, Kelsey KT, Arcaro KF. Sturgeon SR, et al. Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1575-1581. doi: 10.1158/1055-9965.EPI-20-1717. Epub 2021 Jun 9. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34108140 Free PMC article. Clinical Trial.

6

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.

Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Schairer C, et al. JAMA. 2000 Jan 26;283(4):485-91. doi: 10.1001/jama.283.4.485. JAMA. 2000. PMID: 10659874

7

Geographic variation in mortality from breast cancer among white women in the United States.

Sturgeon SR, Schairer C, Gail M, McAdams M, Brinton LA, Hoover RN. Sturgeon SR, et al. J Natl Cancer Inst. 1995 Dec 20;87(24):1846-53. doi: 10.1093/jnci/87.24.1846. J Natl Cancer Inst. 1995. PMID: 7494228

8

Evidence of a healthy estrogen user survivor effect.

Sturgeon SR, Schairer C, Brinton LA, Pearson T, Hoover RN. Sturgeon SR, et al. Epidemiology. 1995 May;6(3):227-31. doi: 10.1097/00001648-199505000-00006. Epidemiology. 1995. PMID: 7619927 Clinical Trial.

9

Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States).

Schairer C, Byrne C, Keyl PM, Brinton LA, Sturgeon SR, Hoover RN. Schairer C, et al. Among authors: sturgeon sr. Cancer Causes Control. 1994 Nov;5(6):491-500. doi: 10.1007/BF01831376. Cancer Causes Control. 1994. PMID: 7827235

10

Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.

Sturgeon SR, Sherman ME, Kurman RJ, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Brinton LA. Sturgeon SR, et al. Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):231-5. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9521439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page